Exploratory PK/PD analysis 

To facilitate decision-making within the drug development program, Kinesis can perform exploratory analyses with short turn-around times. Based on interim data, models can be built to predict PK and/or PD for desired dose groups or for predictions of exposure after multiple dosing based on single dose data. In general this construction is used within early Phase I and Phase IIa studies, where the work contributes to a well-founded decision for subsequent dose groups and/or future study designs.



Consultants in drug development

Consultant in drug development

Print this page